Medichem Pharmaceutical India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.47 M
as on 12-12-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Medichem Pharmaceutical India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.47 M, as per Ministry of Corporate Affairs (MCA) records.
Lalit Bohra, Mamta Thakur, Sarla Bohra, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232DL1998PTC092579
- Company No.
092579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medichem Pharmaceutical India Private Limited offer?
Medichem Pharmaceutical India Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herb Leaves.
Who are the key members and board of directors at Medichem Pharmaceutical India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Bohra  | Director | 03-Oct-2018 | Current |
| Mamta Thakur | Director | 06-Mar-1998 | Current |
| Sarla Bohra | Director | 06-Aug-2018 | Current |
| Vidya Thakur | Director | 03-Oct-2018 | Current |
Financial Performance of Medichem Pharmaceutical India.
Enhance accessibility to Medichem Pharmaceutical India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medichem Pharmaceutical India?
Unlock access to Medichem Pharmaceutical India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medichem Pharmaceutical India?
Unlock and access historical data on people associated with Medichem Pharmaceutical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medichem Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medichem Pharmaceutical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
